SomantiX is a Dutch biotech company SomantiX focuses on the development of therapeutics of solid cancers through direct targeting tumor blood vessels. The SomantiX R&D programs focus on target discovery, validation and drug development.
Company (Alive / Active)
Phone: +31 (0)30-7600976
Hugo R. Kruyt building , Floor 8, Room O.807
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)